相关实验视频
Updated: Jul 9, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
133
在类风湿性关节炎中IFN-α的作用
Chung M A Lin1,2, John D Isaacs1,2, Faye A H Cooles3,4
1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Current rheumatology reports
|December 5, 2023
概括
1型干扰素 (IFN-I) 在类风湿性关节炎 (RA) 病理生理学中发挥作用. 需要进一步的研究来了解IFN-I生物学,并开发针对RA的向疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 1型干扰素 (IFN-I) 在自身免疫性类风湿性疾病中越来越受关注.
- 关于IFN-I在类风湿性关节炎 (RA) 中的作用的研究历来是有限的,但现在正在增加.
- 最近的发现表明IFN-I对RA病理生理学的潜在贡献.
研究的目的:
- 审查IFN-I在RA中的作用,考虑疾病阶段.
- 探索IFN-I在RA中直接影响的细胞功能.
- 检查IFN-I信号对临床轨迹和遗传风险因素的影响.
主要方法:
- 文献综述,重点关注近期在RA的IFN-I研究的进展.
- 分析受IFN-I影响的细胞功能.
- 探索与IFN-I信号相关的环境触发因素和遗传风险因素.
主要成果:
- IFN-I信号影响了与RA相关的各种细胞功能.
- 在RA的临床轨迹可能会受到IFN-I信号的增加的影响.
- 确定了IFN-I暴露,表观遗传变化和RA过程之间的潜在联系.
结论:
- IFN-I可能在RA的发病过程中发挥作用.
- 关于RA的IFN-I生物学,特别是风险人群的知识缺口存在.
- 未来的研究应该专注于了解IFN-I生物学,并制定针对RA的向治疗策略.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168

